Answers are grounded in this paper and cite their sources.
Multicenter registry analysis reveals no beneficial use of the wearable cardioverter defibrillator in congenital heart disease, highlighting lacking evidence for clinical guidelines.
Data on the use of the wearable cardioverter defibrillator in patients suffering from inherited and congenital heart disease are limited. Consequently, evidence for guideline recommendations in this patient population is lacking.
No takes yet. Share an insight, caveat, or question.
Koepsel et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: